Researchers have uncovered differences in how patients with South Asian and white ethnicity present with inflammatory bowel ...

Many with Crohn’s disease or ulcerative colitis sacrifice essential purchases like food and clothing for healthcare, survey ...

The FDA granted approval to Eli Lilly and Company’s mirikizumab-mrkz (Omvoh) for Crohn disease, expanding its treatment reach ...

In a major breakthrough, researchers in the UK have discovered a potential root cause of inflammatory bowel disease (IBD), a ...

effective treatment, and improved quality of life. One of the hallmark symptoms of IBD is abdominal discomfort, often accompanied by cramping. In Crohn’s disease, this pain is typically located ...

Inflammatory Bowel Disease (IBD) is a term for chronic inflammatory conditions affecting the digestive tract, primarily Crohn ...

Over 80% of patients maintained endoscopic response after two years of continuous Omvoh treatment in ongoing studies. Get the ...

Lilly has also submitted marketing applications for Mirikizumab-mrkz in Crohn’s disease around the globe, including in the ...

Medications are often an important part of IBD treatment. IBD is an immune-mediated disease that causes persistent inflammation in the GI tract. Without treatment, it can continue to damage the GI ...

Takeda and the EU’s Innovative Health Initiative have announced a €‎38m project aimed at improving early intervention in ...

Takeda is serving as the Industry Lead in the newly launched INTERCEPT project to identify predictive biomarkers for Crohn's ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...